Filing Details
- Accession Number:
- 0001388658-20-000161
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-05 17:14:37
- Reporting Period:
- 2020-08-03
- Accepted Time:
- 2020-08-05 17:14:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670676 | A David Vort | C/O Irhythm Technologies, Inc. 699 8Th St #600 San Francisco CA 94103 | Evp, Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-03 | 5,264 | $8.18 | 21,267 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-03 | 1,718 | $124.87 | 19,549 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-03 | 2,425 | $125.50 | 17,124 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-03 | 1,121 | $126.10 | 16,003 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-08-03 | 5,264 | $0.00 | 5,264 | $8.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,599 | 2019-12-15 | 2025-12-15 | No | 4 | M | Direct |
Footnotes
- The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2020.
- This transaction was executed in multiple trades at prices ranging from $124,02 to $125.01 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple trades at prices ranging from $125.065 to $126.055 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple trades at prices ranging from $126.06 to $126.36 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This option is fully vested and exercisable in full.
Billionaire Hedge Funds
